Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/13/2014CA2599376C Roflumilast for the treatment of diabetes mellitus
05/13/2014CA2599228C Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives
05/13/2014CA2599018C Methods and systems for operating an aerosol generator
05/13/2014CA2595481C A tetracycline metal complex in a solid dosage form
05/13/2014CA2594981C Anthelmintic composition
05/13/2014CA2588760C Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives
05/13/2014CA2585334C Indole derivatives useful as progesterone receptor modulators
05/13/2014CA2584681C Pearmease and suicide genes for antitumoral or antiviral treatment
05/13/2014CA2570444C Absorbable stent comprising coating for controlling degradation and maintaining ph neutrality
05/13/2014CA2560826C Antioxidant-promoting herbal extract compositions for alleviating oxidative stress in a mammal
05/13/2014CA2559733C Inhibitors of histone deacetylase
05/13/2014CA2559408C Carboline derivatives useful in the inhibition of angiogenesis
05/13/2014CA2550704C Nicotine transdermal delivery system
05/13/2014CA2539872C Compositions for conjugated estrogens and associated methods
05/13/2014CA2520855C Imidazopyridine derivatives as melanocortin receptor agonists
05/13/2014CA2518780C Drug composition having active ingredient adhered at high concentration to spherical core
05/13/2014CA2514058C Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
05/13/2014CA2513759C Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same
05/13/2014CA2506850C Compounds and methods for increasing neurogenesis
05/13/2014CA2417552C Compositions and methods for treating females sexual response
05/13/2014CA2270345C Immunostimulatory nucleic acid molecules
05/12/2014CA2797752A1 Methods of designing, preparing, and using novel protonophores
05/09/2014CA2795324A1 Pharmaceutical compositions comprising hydromorphone and naloxone
05/08/2014WO2014071389A1 Ketone bodies to protect tissues from damage by ionizing radiation
05/08/2014WO2014071387A1 Composition and method for delivery of hydrophobic active agents
05/08/2014WO2014071379A1 Dosing and administration of oligonucleotide cancer therapies
05/08/2014WO2014071378A1 Substituted indol-5-ol derivatives and their therapeutical applications
05/08/2014WO2014071371A1 Cocrystals of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate
05/08/2014WO2014071369A1 Tricyclic compounds for use in the treatment and/or control of obesity
05/08/2014WO2014071368A1 Methods of treating liver diseases
05/08/2014WO2014071363A1 Tricyclic compounds and methods of making and using same
05/08/2014WO2014071355A1 1,3,4-oxadiazoles-2-thio azetidine derivatives as sphingosine-1 phosphate receptors modulators
05/08/2014WO2014071342A1 1,3,4-oxadiazoles-2-thio derivatives as sphingosine-1 phosphate receptors modulators
05/08/2014WO2014071339A2 Uses of bremelanotide in therapy for female sexual dysfunction
05/08/2014WO2014071298A1 Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
05/08/2014WO2014071283A1 Cephalosporin derivatives and methods of use
05/08/2014WO2014071280A1 Treatment of cancer with pomalidomide in a renally impaired subject
05/08/2014WO2014071247A1 Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
05/08/2014WO2014071241A1 Disubstituted amino acids and methods of preparation and use thereof
05/08/2014WO2014071231A1 Tec family kinase inhibitor adjuvant therapy
05/08/2014WO2014071219A1 Methods and products for expressing proteins in cells
05/08/2014WO2014071205A1 Compositions and methods for diagnosis, prognosis and treatment of hematological malignancies
05/08/2014WO2014071203A1 Sustained release of topical anesthetics
05/08/2014WO2014071198A1 Antibiotic methods and compositions for bacteria infections
05/08/2014WO2014071194A2 Methods for treating fibromyalgia
05/08/2014WO2014071190A1 Egcg stabilized gold nanoparticles and method for making same
05/08/2014WO2014071176A1 Nutritional supplements including meal replacements and related methods
05/08/2014WO2014071155A1 Therapeutic uses of tigemonam and carumonam
05/08/2014WO2014071149A1 Heparanase and its uses related to exostoses
05/08/2014WO2014071143A1 Method for treating prostate cancer
05/08/2014WO2014071134A1 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
05/08/2014WO2014071128A1 Macrophage-derived matrix vesicles: an alternative mechanism for microcalcification in atherosclerotic plaques
05/08/2014WO2014071125A1 Combination of anti-cd20 antibody and pi3 kinase selective inhibitor
05/08/2014WO2014071122A1 Pharmaceutical compositions for the treatment of cftr mediated diseases
05/08/2014WO2014071109A1 Treatment of cancers using pi3 kinase isoform modulators
05/08/2014WO2014071105A1 Treatment of rheumatoid arthritis and asthma using p13 kinase inhibitors
05/08/2014WO2014071067A2 Treatment and diagnosis of colon cancer
05/08/2014WO2014071044A1 Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
05/08/2014WO2014071031A1 Tricyclic fused thiophene derivatives as jak inhibitors
05/08/2014WO2014071005A1 Methods and compositions using neuroprotective steroids and thrombolytic agents
05/08/2014WO2014071000A1 Class of hdac inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury
05/08/2014WO2014070991A2 E-selectin antagonist compounds and methods of use
05/08/2014WO2014070983A1 Plasminogen activator-1 inhibitors and methods of use thereof
05/08/2014WO2014070979A1 Inhibitors of cytomegalovirus
05/08/2014WO2014070978A1 Inhibitors of cytomegalovirus
05/08/2014WO2014070976A1 Inhibitors of cytomegalovirus
05/08/2014WO2014070948A1 Combination therapies
05/08/2014WO2014070859A1 Stat3 dimerization inhibitors
05/08/2014WO2014070840A2 Stimulating bone formation by inhibition of cd28 co-stimulation
05/08/2014WO2014070774A1 Methods of generating beta-lactamase resistant carbapenem compounds
05/08/2014WO2014070771A1 Pyrimidine nucleotides and their monophosphate prodrugs for treatment of viral infections and cancer
05/08/2014WO2014070769A1 Methods and compositions for treating mucosal tissue disorders
05/08/2014WO2014070760A1 Use of resazurin, or analogs thereof, for antibacterial therapy
05/08/2014WO2014070745A1 Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof
05/08/2014WO2014070709A1 Novel mucosal adjuvants and delivery systems
05/08/2014WO2014070706A1 Control of cardiac growth, differentiation and hypertrophy
05/08/2014WO2014070696A2 Medicinal treatment of chronic dermal inflammatory diseases with norketotifen
05/08/2014WO2014070673A1 Artemisinin derivatives, methods for their preparation and their use as antimalarial agents
05/08/2014WO2014070622A1 Propynylaminoindan transdermal compositions
05/08/2014WO2014070523A1 Trans-clomiphene for use in cancer therapy
05/08/2014WO2014070517A1 Methods and compositions for treating progesterone-dependent conditions
05/08/2014WO2014070371A1 Improved method of making internal dehydration products of sugar alcohols
05/08/2014WO2014070370A1 Additives for improved isohexide products
05/08/2014WO2014070214A1 Anti-tumor agent otx-008 targets human galectin-1
05/08/2014WO2014070210A2 Antimicrobial hoof bath compositions and methods of using same
05/08/2014WO2014070111A1 A novel reagent for gene-drug therapeutics
05/08/2014WO2014070038A1 Solid dosage form having neuroprotective, antiamnesic, antioxidant, antihypoxic and anti-ischemic activity (variants)
05/08/2014WO2014070016A2 Synbiotics combination for brain improvement
05/08/2014WO2014070014A1 Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
05/08/2014WO2014069963A1 Thioaryl derivatives as gpr120 agonists
05/08/2014WO2014069846A1 Method for preparing 1-deoxy-1-(2-hydroxyethyl amino)-d-glucitol and miglitol
05/08/2014WO2014069837A1 Histamine receptor antagonist composition containing gamma oryzanol as active ingredient
05/08/2014WO2014069836A1 Histamine receptor antagonist composition containing policosanol as active ingredient
05/08/2014WO2014069801A1 Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases
05/08/2014WO2014069800A1 Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases
05/08/2014WO2014069799A1 Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases
05/08/2014WO2014069667A1 Agent for preventing or improving decline in brain function
05/08/2014WO2014069666A1 Agent for preventing or improving decline in brain function
05/08/2014WO2014069665A1 Composition for animal parasite extermination and method for animal parasite extermination
05/08/2014WO2014069660A1 Blood flow promoting agent
1 ... 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 ... 7860